Accuracy of SmartWATCH-based ElectroCardioGraphic arrhythmia detection

Accuracy of SmartWATCH-based ElectroCardioGraphic arrhythmia detection - WATCH-ECG II

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON48038

Enrollment

530

Registered

2019-08-06

Start date

2019-08-29

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Afib irregular heart rhythm

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - 18 years of age or older; - Willing and able to provide written informed consent; - Must have an indication to undergo routine 12-lead ECG testing; - Willing to undergo an additional simultaneous ECG recording using the Apple Watch.

Exclusion criteria

Exclusion criteria: - Unwilling or unable to provide written informed consent.

Design outcomes

Primary

Measure	Time frame
Main study endpoint This study is designed to assess diagnostic accuracy, as defined by sensitivity and specificity, of a commercially available heart rate monitor (Apple Watch) in heart rhythm classification (AF or SR).	—

Secondary

Measure	Time frame
None.	—

Countries

Netherlands

Outcome results